E1	Assertion:T1 Asserted:E5
E2	Modifier:T2 Modifies:T41
E3	Or:T3 Arg:E2 Arg2:E4
E4	Modifier:T4 Modifies:T41
E5	Condition:T5 Name:T41
E6	And:T6 Arg:E5 Arg2:E7
E7	Indication:T7 Indication-For:E8 Indication-For2:E9 Indication-For3:E11
E8	Procedure:T8 Name:T42
E9	Procedure:T9 Name:T43
E10	Or:T10 Arg:E9 Arg2:E11
E11	Procedure:T11 Name:T44
E12	Age:T12 Eq-Comparison:E13
E13	Eq-Comparison:T13 Operator:T45 Temporal-Unit:T46 Value:T63
E14	Observation:T14 Name:T64 Eq-Comparison:E15
E15	Eq-Comparison:T15 Value:T47 Operator:T48 Value2:T49
E16	Procedure:T16
E17	And:T17 Arg:E16 Arg2:E18
E18	Encounter:T18
E19	Other:T19 Is-Other:E21
E20	Eq-Comparison:T20 Temporal-Period:T50
E21	Condition:T21 Name:T51 Temporality:E20 Temporality2:E22
E22	Eq-Comparison:T22 Temporal-Period:T52 Value:T53 Temporal-Unit:T54
E23	Temporal-Connection:T23 Arg:E22 Arg2:E25
E25	Study:T25
E26	Exception:T26 From:E21 Except:E29
E27	Procedure:T27
E28	Modifier:T28 Modifies:T55
E29	Condition:T29 Name:T55
E30	Condition:T30 Name:T57 Severity:T56
E31	Condition:T31 Name:T58
E32	Condition:T32 Name:T59
E33	Modifier:T33 Modifies:T59
E34	Or:T34 Arg:E33 Arg2:E42
E35	Eq-Comparison:T35 Temporal-Period:T60
E36	Procedure:T36 Name:T61 Temporality:E35
E37	Modifier:T37 Modifies:T62
E38	Or:T38 Arg:E37 Arg2:E39
E39	Modifier:T39 Modifies:T62
E40	Condition:T40 Name:T62
E41	Assertion:T65 Asserted:E16 Asserted2:E18
E24	Negation:T24 Negates:E28
E42	Modifier:T66 Modifies:T59
E43	Modifier:T67 Modifies:T59
E44	Study:T68
E45	Negation:T69 Negates:E44
E46	Assertion:T70 Asserted:E45
T1	Assertion 40 49	suspicion
T2	Modifier 54 61	primary
T3	Or 62 64	or
T4	Modifier 65 74	recurrent
T5	Condition 75 78	EOC
T6	And 79 83	with
T7	Indication 87 97	indication
T8	Procedure 102 109	surgery
T9	Procedure 111 123	chemotherapy
T10	Or 124 130	and/or
T11	Procedure 131 144	immunotherapy
T12	Age 151 154	Age
T13	Eq-Comparison 155 164	≥18 years
T14	Observation 171 193	WHO performance status
T15	Eq-Comparison 194 197	0-2
T16	Procedure 219 228	treatment
T17	And 229 232	and
T18	Encounter 233 242	follow-up
T19	Other 300 305	Other
T20	Eq-Comparison 306 312	active
T21	Condition 313 323	malignancy
T22	Eq-Comparison 327 339	past 5 years
T23	Temporal-Connection 340 348	prior to
T25	Study 364 369	study
T26	Exception 371 377	except
T27	Procedure 382 389	treated
T28	Modifier 394 407	melanoma skin
T29	Condition 408 414	cancer
T30	Condition 438 447	infection
T31	Condition 453 456	HIV
T32	Condition 458 467	hepatitis
T33	Modifier 471 472	B
T34	Or 473 476	and
T35	Eq-Comparison 485 494	Receiving
T36	Procedure 495 523	immune suppressive treatment
T37	Modifier 530 537	Medical
T38	Or 538 540	or
T39	Modifier 541 554	psychological
T40	Condition 555 564	condition
T41	Condition-Name 75 78	EOC
T42	Procedure-Name 102 109	surgery
T43	Procedure-Name 111 123	chemotherapy
T44	Procedure-Name 131 144	immunotherapy
T45	Eq-Operator 155 156	≥
T46	Eq-Temporal-Unit 159 164	years
T47	Eq-Value 194 195	0
T48	Eq-Operator 195 196	-
T49	Eq-Value 196 197	2
T50	Eq-Temporal-Period 306 312	active
T51	Condition-Name 313 323	malignancy
T52	Eq-Temporal-Period 327 331	past
T53	Eq-Value 332 333	5
T54	Eq-Temporal-Unit 334 339	years
T55	Condition-Name 408 414	cancer
T56	Severity 431 437	severe
T57	Condition-Name 438 447	infection
T58	Condition-Name 453 456	HIV
T59	Condition-Name 458 467	hepatitis
T60	Eq-Temporal-Period 485 494	Receiving
T61	Procedure-Name 495 523	immune suppressive treatment
T62	Condition-Name 555 564	condition
T63	Eq-Value 156 158	18
T64	Observation-Name 171 193	WHO performance status
T65	Assertion 204 218	Accessible for
T24	Negation 390 393	non
T66	Modifier 477 478	C
T67	Modifier 468 469	A
T68	Study 651 656	study
T69	Negation 612 615	not
T70	Assertion 612 615	not
A1	Assertion-Type-Value E1 possible
A2	Temporal-Connection-Type-Value E23 before
A3	Eq-Operator-Value T45 GTEQ
A4	Eq-Temporal-Unit-Value T46 year
A5	Eq-Operator-Value T48 BETWEEN
A6	Eq-Temporal-Period-Value T50 present
A7	Eq-Temporal-Period-Value T52 past
A8	Eq-Temporal-Unit-Value T54 year
A9	Severity-Value T56 severe
A10	Eq-Temporal-Period-Value T60 present
A11	Observation-Type-Value T64 clinical-score
A12	Assertion-Type-Value E41 hypothetical
A13	Assertion-Type-Value E46 hypothetical
R1	Treatment-For Arg1:E27 Arg2:E29
R2	Example-Of Arg1:E31 Arg2:E30
R3	Caused-By Arg1:E45 Arg2:E40